Sialic acid as a potential biomarker for cardiovascular disease, diabetes and cancer

Financial support from the MRC and Ludger Ltd, is gratefully acknowledged. DIR Spencer and RA Gardner are employed by Ludger Ltd, a company that commercializes glycoanalytical tests. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

留言 (0)

沒有登入
gif